Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (81-90 of 407) with videos related to

Pageof 41
Sort By:
Nature Communications|August 19, 2022
Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron eraRosanna C Barnard, Nicholas G Davies, , et al.
The Lancet. Public Health|November 24, 2023
Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and prioritiesHaijun Zhang, Xiaozhen Lai, Bryan N Patenaude, et al.
BMC Medicine|August 9, 2023
Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccinesNaomi R Waterlow, Simon R Procter, Rosalind M Eggo, et al.
Pharmacoeconomics|March 7, 2026
Correction: Estimating the Value of Combination Vaccines: A Methodological FrameworkMark Jit, Allison Portnoy, Clint Pecenka, et al.
Epidemics|November 19, 2011
What types of contacts are important for the spread of infections?: using contact survey data to explore European mixing patternsAlessia Melegaro, Mark Jit, Nigel Gay, et al.
Medrxiv : the Preprint Server for Health Sciences|November 30, 2021
Behaviour, booster vaccines and waning immunity: modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron eraRosanna C Barnard, Nicholas G Davies, , et al.
The Lancet Regional Health. Western Pacific|June 30, 2026
Cost-effectiveness and health impact of gender-neutral and single-dose HPV vaccination in Hong Kong: a modeling analysisHorace Cheuk Wai Choi, Kathy Leung, Mark Jit, et al.
Pharmacoeconomics|January 4, 2026
Estimating the Value of Combination Vaccines: A Methodological FrameworkMark Jit, Allison Portnoy, Clint Pecenka, et al.
Plos One|July 19, 2012
Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and WalesYoon Hong Choi, Mark Jit, Stefan Flasche, et al.
Scientific Reports|August 13, 2017
Social contact patterns relevant to the spread of respiratory infectious diseases in Hong KongKathy Leung, Mark Jit, Eric H Y Lau, et al.
Pageof 41

Showing results (81-90 of 407) with videos related to

Sort By:
Pageof 41
Nature Communications|August 19, 2022
Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron eraRosanna C Barnard, Nicholas G Davies, , et al.
The Lancet. Public Health|November 24, 2023
Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and prioritiesHaijun Zhang, Xiaozhen Lai, Bryan N Patenaude, et al.
BMC Medicine|August 9, 2023
Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccinesNaomi R Waterlow, Simon R Procter, Rosalind M Eggo, et al.
Pharmacoeconomics|March 7, 2026
Correction: Estimating the Value of Combination Vaccines: A Methodological FrameworkMark Jit, Allison Portnoy, Clint Pecenka, et al.
Epidemics|November 19, 2011
What types of contacts are important for the spread of infections?: using contact survey data to explore European mixing patternsAlessia Melegaro, Mark Jit, Nigel Gay, et al.
Medrxiv : the Preprint Server for Health Sciences|November 30, 2021
Behaviour, booster vaccines and waning immunity: modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron eraRosanna C Barnard, Nicholas G Davies, , et al.
The Lancet Regional Health. Western Pacific|June 30, 2026
Cost-effectiveness and health impact of gender-neutral and single-dose HPV vaccination in Hong Kong: a modeling analysisHorace Cheuk Wai Choi, Kathy Leung, Mark Jit, et al.
Pharmacoeconomics|January 4, 2026
Estimating the Value of Combination Vaccines: A Methodological FrameworkMark Jit, Allison Portnoy, Clint Pecenka, et al.
Plos One|July 19, 2012
Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and WalesYoon Hong Choi, Mark Jit, Stefan Flasche, et al.
Scientific Reports|August 13, 2017
Social contact patterns relevant to the spread of respiratory infectious diseases in Hong KongKathy Leung, Mark Jit, Eric H Y Lau, et al.
Pageof 41